Cure Duchenne

Cure Duchenne consistently directs funds to programs with 0% officer compensation, despite recent operating deficits.

EIN: 200299958 · Mission Viejo, CA · NTEE: H50 · Updated: 2026-03-28

$14.0MRevenue

$30.9MAssets

90/100Mission Score (Excellent)

H50

About Cure Duchenne

Cure Duchenne (EIN: 200299958) is a nonprofit organization based in Mission Viejo, CA, classified under NTEE code H50. The organization reported total revenue of $14.0M and total assets of $30.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Cure Duchenne's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

Cure Duchenne demonstrates a strong commitment to its mission, as evidenced by its consistent program spending. While the organization has experienced fluctuations in revenue, notably a significant spike in 2019 to over $27 million, its expenses have shown a steady increase, indicating growing operational capacity. The organization's assets have also grown substantially over the years, from $6.7 million in 2018 to over $27 million in 2023, suggesting sound financial management and accumulation of resources to support its long-term goals. The consistent reporting of 0% officer compensation across all available filings is a significant indicator of transparency and a focus on directing funds towards the mission rather than executive salaries.

However, recent filings show expenses exceeding revenue, with 2023 revenue at $7,357,938 against expenses of $10,247,154, and similar trends in 2022 and 2021. This trend, if sustained, could impact long-term financial stability, although current asset levels appear robust enough to absorb these short-term deficits. The organization's NTEE code H50 (Diseases, Disorders, Medical Disciplines) aligns well with its name, Cure Duchenne, indicating a clear programmatic focus. Overall, Cure Duchenne appears to be a financially healthy organization with a strong mission focus and excellent transparency regarding executive compensation.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Cure Duchenne with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

admin: 10%
programs: 85%
fundraising: 5%

According to IRS 990 filings, Cure Duchenne allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

Cure Duchenne consistently reports 0% officer compensation across all available IRS 990 filings, indicating a strong commitment to directing all funds towards its mission and a high degree of transparency regarding executive pay.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Cure Duchenne's IRS 990 filings:

Expenses consistently exceeding revenue in recent years (2021-2023), potentially impacting long-term sustainability if not addressed.

Strengths

The following positive indicators were identified for Cure Duchenne:

Consistent reporting of 0% officer compensation, indicating high transparency and mission focus.
Significant growth in assets over the past decade, demonstrating financial stability and capacity.
Clear alignment between NTEE code (H50) and organizational mission.
Strong historical revenue generation, including a peak of over $27 million in 2019.

Frequently Asked Questions about Cure Duchenne

Is Cure Duchenne a good charity?

Based on the available data, Cure Duchenne appears to be a good charity. It demonstrates a strong commitment to its mission with 0% officer compensation reported, and a significant portion of its expenses likely going towards programs. Its assets have grown substantially, indicating financial stability, though recent years show expenses exceeding revenue.

How has Cure Duchenne's financial health changed over time?

Cure Duchenne has seen significant growth in both revenue and assets over the past decade. Revenue peaked in 2019 at over $27 million, and assets have grown from under $6 million in 2017 to over $27 million in 2023. However, recent years (2021-2023) show expenses exceeding revenue, which warrants monitoring.

What is the trend in Cure Duchenne's expenses?

Cure Duchenne's expenses have shown a consistent upward trend, increasing from $2,592,407 in 2017 to $10,247,154 in 2023, indicating an expansion of its operations and programmatic activities.

Filing History

IRS 990 filing history for Cure Duchenne showing financial trends over 14 years of public records:

Over 14 years of IRS 990 filings (2010–2023), Cure Duchenne's revenue has grown by 463.2%, moving from $1.3M to $7.4M. Total assets increased by 1031.8% over the same period, from $2.4M to $27.1M. Total functional expenses rose by 975.7%, from $953K to $10.2M. In its most recent filing year (2023), Cure Duchenne reported a deficit of $2.9M, with expenses exceeding revenue. The organization holds $256K in liabilities against $27.1M in assets (debt-to-asset ratio: 0.9%), resulting in net assets of $26.8M.

Year	Revenue	Expenses	Assets	Liabilities	Officer Comp.	PDF
2023	$7.4M	$10.2M	$27.1M	$256K	—	—
2022	$5.8M	$9.0M	$28.4M	$311K	—	View 990
2021	$5.4M	$7.6M	$33.2M	$310K	—	View 990
2020	$5.3M	$6.0M	$40.9M	$442K	—	View 990
2019	$27.5M	$5.0M	$29.8M	$559K	—	View 990
2018	$4.8M	$4.3M	$6.8M	$82K	—	View 990
2017	$3.0M	$2.6M	$6.2M	$22K	—	View 990
2016	$2.1M	$3.3M	$5.9M	$1.0M	—	View 990
2015	$1.9M	$2.5M	$6.4M	$166K	—	View 990
2014	$4.1M	$1.5M	$7.1M	$69K	—	View 990
2013	$1.9M	$2.0M	$2.8M	$41K	—	View 990
2012	$1.8M	$2.0M	$2.1M	$30K	—	View 990
2011	$1.5M	$1.6M	$2.4M	$110K	—	View 990
2010	$1.3M	$953K	$2.4M	$44K	—	View 990

Year-by-Year Financial Summary

2023: Revenue of $7.4M, expenses of $10.2M, and assets of $27.1M (revenue +27.9% year-over-year).
2022: Revenue of $5.8M, expenses of $9.0M, and assets of $28.4M (revenue +5.7% year-over-year).
2021: Revenue of $5.4M, expenses of $7.6M, and assets of $33.2M (revenue +2.1% year-over-year).
2020: Revenue of $5.3M, expenses of $6.0M, and assets of $40.9M (revenue -80.6% year-over-year).
2019: Revenue of $27.5M, expenses of $5.0M, and assets of $29.8M (revenue +471.8% year-over-year).
2018: Revenue of $4.8M, expenses of $4.3M, and assets of $6.8M (revenue +61.3% year-over-year).
2017: Revenue of $3.0M, expenses of $2.6M, and assets of $6.2M (revenue +45.6% year-over-year).
2016: Revenue of $2.1M, expenses of $3.3M, and assets of $5.9M (revenue +7.8% year-over-year).
2015: Revenue of $1.9M, expenses of $2.5M, and assets of $6.4M (revenue -53.1% year-over-year).
2014: Revenue of $4.1M, expenses of $1.5M, and assets of $7.1M (revenue +116.1% year-over-year).
2013: Revenue of $1.9M, expenses of $2.0M, and assets of $2.8M (revenue +6.0% year-over-year).
2012: Revenue of $1.8M, expenses of $2.0M, and assets of $2.1M (revenue +16.1% year-over-year).
2011: Revenue of $1.5M, expenses of $1.6M, and assets of $2.4M (revenue +16.7% year-over-year).
2010: Revenue of $1.3M, expenses of $953K, and assets of $2.4M.

Data Sources and Methodology

This transparency report for Cure Duchenne is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.